Big Pharma Split Corp. (PRM)
TSX
Closed
Aug 24, 2026
Day's Range
15.4852 wk Range
11.58Overview - PRM - Big Pharma Split Corp.
Key Statistics
Valuation
P/E (Trailing)
‪12.00‬
Price / Sales (TTM)
‪3.52‬
Profitability
Return on Assets
‪13.82%‬
Return on Equity
‪24.08%‬
Ownership
Shares Outstanding
1.30M
Price stats
50-Day Avg
‪14.36‬
200-Day Avg
‪14.04‬
Dividends
Frequency
Monthly
Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PRM - Big Pharma Split Corp.
Peers - PRM - Big Pharma Split Corp.
Peer Comparison
Compared with companies in Asset Management listed on TSX.
- PRMTSXBig Pharma Split Corp.19.57MMarket Cap+20.72%52-week change12.00P/E (Trailing)—Profit Margin
- BRKTSXBerkshire Hathaway Inc.1.39TMarket Cap-0.14%52-week change11.83P/E (Trailing)‪22.29%‬Profit Margin
- CLDNTSXCaledonia Investments plc197.07BMarket Cap+2.34%52-week change14.85P/E (Trailing)—Profit Margin
- BLKTSXBlackRock, Inc.165.34BMarket Cap+1.02%52-week change26.46P/E (Trailing)‪24.39%‬Profit Margin
- BXTSXBlackstone Inc.140.45BMarket Cap-20.97%52-week change29.98P/E (Trailing)‪21.21%‬Profit Margin
- BNTSXBrookfield Corporation128.22BMarket Cap-4.50%52-week change76.53P/E (Trailing)‪1.77%‬Profit Margin
- BAMTSXBrookfield Asset Management Inc.115.00BMarket Cap-14.61%52-week change30.37P/E (Trailing)‪48.89%‬Profit Margin
Profile Summary - PRM - Big Pharma Split Corp.
About
Big Pharma Split Corp. is a specialized investment corporation focused on providing investors with exposure to large pharmaceutical companies. Its primary function is to invest in a diversified portfolio of prominent pharmaceutical firms, offering both capital appreciation and dividend income. The corporation…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
